AzTrials
AzTrials

Pediatric ObesityiPOP-UPNCT03648242

Improving Pediatric Obesity Practice Using Prompts

A study testing Interruptive Clinical Decision Support in people with Pediatric Obesity, run by Yale University at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This study compares the effectiveness of electronic health record (EHR)-based tools to support the management of pediatric obesity in primary care. All clinicians will receive an interruptive "pop-up" alert We will examine the impact -- the added value versus unintended consequences -- of the interruptive alert on the… Read more about this study

Who is it for?
Any age
Conditions the study is for
Pediatric Obesity
What is being tested?
Interruptive Clinical Decision Support
Could I receive a placebo?
No, everyone receives an active treatment
How many people
140 participants
Where
1 siteUnited States
Study dates
1 Sep 2018to 31 Dec 2020
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages Any age
  • All sexes
  • No healthy volunteers
  • Child, Adult, Older adult

All pediatric primary care providers providing well child care for patients ages 2-17 years-old in the Boston Children's Hospital primary care practices will be eligible for the study. There are no exclusion criteria.

Trial locations and contacts

1 site in 1 country.

United States1 site
  • Boston Children's Hospital

    Boston, Massachusetts, 02115

Other trials in United States

About this study

Official title: Improving Pediatric Obesity Practice Using Prompts (iPOP-UP): Using Electronic Health Records to Support Decision-Making in Pediatric Obesity Care

This study compares the effectiveness of electronic health record (EHR)-based tools to support the management of pediatric obesity in primary care. All clinicians will receive an interruptive "pop-up" alert We will examine the impact -- the added value versus unintended consequences -- of the interruptive alert on the quality of obesity management in pediatric primary care.

Read the detailed description

The primary specific aims of this study are to:

  1. To assess the impact of EHR-based tools for pediatric obesity in primary care. Hypotheses: EHR-based clinical decision support tools that interrupt but support clinical workflow will (1) improve measures of pediatric obesity care quality delivered by clinicians (e.g., addition of obesity to the problem list, recommended screening for comorbidities, and follow-up/referral plans) and (2) result in a reduced rate of BMI increase over one year among children with obesity.
  2. To utilize a mixed methods approach with surveys and semi-structured qualitative interviews with clinicians to (1) examine the extent to which the EHR tools positively impact clinicians' awareness, knowledge and adherence to expert guidelines for pediatric obesity management, and (2) to explore the barriers to and facilitators of clinicians' use of the EHR tools and factors that influence adoption.
Being tested
Interruptive Clinical Decision Support
Keywords
pediatric obesity, electronic health record, clinical decision support
Medical subject headings
Pediatric Obesity

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Interruptive Clinical Decision SupportBehavioural

    An interruptive, "soft-stop" alert will pop up when a pediatric primary care provider open a child's electronic health record (i.e., a new window in the forefront of the screen interrupting workflow and requiring the clinician to take an action) alerting them that the child meets criteria for obesity based on their age/sex-specific BMI percentile. The pop-up alert includes:

    • One-click addition of elevated BMI to problem list
    • Reminder to utilize Suggested PowerPlan
    • One-click access to a patient handout on evidence-based behavior change goals (screen time, sugary drinks, physical activity, sleep) and link to additional handouts and resources
    • Tables displaying trends in growth measures, blood pressure and relevant laboratory tests
    • Links to existing, evidence-based childhood obesity screening and management guidelines
Study groups in NCT03648242
Study groupRoleWhat they receive
Interruptive Clinical Decision SupportExperimentalNot described
Receives: Behavioral: Interruptive Clinical Decision Support

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change in body mass index (BMI)

    change in BMI, calculated from height and weight measured as part of routine clinical practice during primary care clinic visits and documented in the EHR

    Measured: 1 year pre-intervention, baseline, and 1 year post-intervention

  2. Change in percent BMI above the 95th percentile (%BMIp95)

    Change in percentage of age/sex-adjusted BMI above the 95th percentile (%BMIp95), calculated from height and weight measured as part of routine clinical practice during primary care clinic visits and documented in the EHR

    Measured: 1 year pre-intervention, baseline, and 1 year post-intervention

  3. Change in documentation of elevated BMI diagnosis

    Change in proportion of patients with obesity who have elevated BMI documented in the EHR

    Measured: 1-year pre-implementation compared to 1-year post-implementation

  4. Change in proportion of patients with obesity

    Change in proportion of patients with obesity who receive age-appropriate screening for comorbidities (blood measure measurement and age-appropriate laboratory screening)

    Measured: 1-year pre-implementation compared to 1-year post-implementation

  5. Change in proportion of patients with obesity who have counseling for obesity-related behavior change documented in the EHR

    Measured: 1-year pre-implementation compared to 1-year post-implementation

  6. Change in proportion of patients with obesity with follow-up or referral orders

    Measured: 1-year pre-implementation compared to 1-year post-implementation

Secondary outcomes (2)
  1. Change in provider knowledge, attitudes and practice around obesity management in primary care assessed via an electronic surveys and qualitative interviews of clinicians

    Measured: baseline compared to 6 months post-implementation

  2. System usability scale (SUS) score

    the system usability scale is a validated 10-item measure of system usability

    Measured: 6 months post-implementation

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted27 Aug 2018
  2. Study start1 Sep 2018
  3. Primary completion30 Sep 2020
  4. Study completion31 Dec 2020

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Health services research
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrolment
140 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03648242
Sponsor's protocol ID
2000026382
Other IDs
1K08HS024332-01A1
Acronym
iPOP-UP
Status last verified
May 2021
First submitted
21 Aug 2018
Last updated
17 May 2021
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Interruptive Clinical Decision Support in people with Pediatric Obesity, run by Yale University at 1 site in United States.

The full registered description is in the About this study section and the official record.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 17 May 2021. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change in body mass index (BMI) (time frame: 1 year pre-intervention, baseline, and 1 year post-intervention). The study lists 6 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 17 May 2021.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in